Teva Announces Long-Term Data Of Austedo In Adult Patients With Tardive Dyskinesia

Teva Pharmaceuticals announced results from a post hoc analysis of a long-term, 3-year open-label extension (OLE) study examining efficacy and safety endpoints for the use of Austedo (deutetrabenazine) tablets in younger (<55 years) and older (=55 years) patients with tardive dyskinesia.

The company said that safety profile of Austedo was generally similar across both the younger and older patients. No determination of statistical significance can be made, due to the uncontrolled nature of the data and post hoc analysis.

The findings, published online in The American Journal of Geriatric Psychiatry, evaluated the long-term use of Austedo with the total motor Abnormal Involuntary Movements Scale (AIMS) score, and measures of treatment success and quality of life.

Austedo tablets is indicated in adults for the treatment of chorea associated with Huntington's disease and for the treatment of tardive dyskinesia in adults.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Royal Caribbean Group's ultra-luxury brand Silversea Cruises is set to launch the world's first hybrid-powered cruise ship in the summer of 2023. This will also be the first ship with large-scale fuel cell technology to enable emission-free port operations. The fuel cells will provide 100% of power while at port. Affco USA is recalling around 24,461 pounds of frozen raw lamb shoulder products that were not presented for import re-inspection into the U.S., the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves the frozen raw lamb shoulder items that were imported on July 12, 2021. American Express Company (AXP) reported an increase in profit for the third quarter that also topped Wall Street estimates. Consolidated total revenues net of interest expense rose 25 percent year-on-year, primarily reflecting growth in Card Member spending, as well as a rise in the average discount...
Follow RTT